The Medipattern Corporation

The Medipattern Corporation

December 01, 2006 18:10 ET

Medipattern Announces Option Grant

TORONTO, ONTARIO--(CCNMatthews - Dec. 1, 2006) -

Attention: Business/Financial Editors

The Medipattern Corporation (TSX VENTURE:MKI), an award-winning developer of computer-aided diagnosis (CAD) software for medical imaging, announced today the granting of options to two new employees, Janet Sterritt (Vice President, Marketing and Sales) and Drew Sala (Director, International Sales), whose appointments were announced on November 21 and 27, 2006, respectively. This grant will vest over three years according to the Company's employee stock option program, and reflects Medipattern's strong commitment to long-term, non-cash rewards for performance.

Effective November 23, 2006, an aggregated 250,000 stock options were granted to Ms Sterritt and Mr. Sala. The options are exercisable for a period of five years from the date of grant at $0.50 a share. At the same time, 300,000 options have been cancelled as a result of an employee departure.

Upcoming Events:

Medipattern's annual general meeting is to be held December 7, 2006 at 10:00 AM EST in the boardroom of WeirFoulds in the Exchange Tower, Suite 1600, 130 King Street West in Toronto. Please contact Robin Sundstrom at 416-368-8770 x223 if you plan to attend.

About The Medipattern Corporation

Medipattern develops computer-aided diagnosis (CAD) software applications for medical imaging. These applications enhance workflow while improving interpretive and diagnostic confidence. The Company's initial clinical applications are B-CAD™ for breast ultrasound and the award-winning B-CAD MRI™. The B-CAD products use pattern recognition technology to assist radiologists in their efforts to classify and characterize lesions in images of the breast. Please visit the company's website at:

B-CAD™ and B-CAD MRI™ are trademarks of The Medipattern Corporation.
Medipattern® is a registered mark of The Medipattern Corporation.

Forward-looking statements

This document contains forward-looking statements relating to Medipattern's performance, operations, or business environment. These statements are based on what we believe are reasonable assumptions given currently available information and our understanding of Medipattern's current activities. We have tried, whenever possible, to identify these forward-looking statements using words such as "anticipates,'' "believes,'' "estimates,'' "expects,'' "plans,'' "intends,'' "potential'', and similar expressions. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that are difficult to predict or control. A number of factors could cause actual outcomes and results to differ materially from those expressed in forward-looking statements. These factors include but are not limited to those set forth in the Company's corporate filings, (posted at In addition, these forward-looking statements relate to the date on which they are made. The Company disclaims any intention or obligation to update or revise any forward-looking statements for any reason. Readers should not rely on forward-looking statements.

The TSX Venture Exchange does not accept responsibility for the adequacy or accuracy of this release and has neither approved nor disapproved of the contents of this release.

Contact Information